BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35372854)

  • 1. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.
    Manohar S; Ghamrawi R; Chengappa M; Goksu BNB; Kottschade L; Finnes H; Dronca R; Leventakos K; Herrmann J; Herrmann SM
    Kidney360; 2020 Jan; 1(1):16-24. PubMed ID: 35372854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience.
    Elghawy O; Patel R; Barsouk A; Puthumana J; Xu J; Sussman J; Horton B; Kaur V
    J Oncol Pharm Pract; 2024 May; ():10781552241252627. PubMed ID: 38706192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.
    Muriithi AK; Leung N; Valeri AM; Cornell LD; Sethi S; Fidler ME; Nasr SH
    Am J Kidney Dis; 2014 Oct; 64(4):558-66. PubMed ID: 24927897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.
    Baker ML; Yamamoto Y; Perazella MA; Dizman N; Shirali AC; Hafez N; Weinstein J; Simonov M; Testani JM; Kluger HM; Cantley LG; Parikh CR; Wilson FP; Moledina DG
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35354588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids.
    Woodruff AE; Meaney CJ; Hansen EA; Prescott GM
    Pharmacotherapy; 2015 Nov; 35(11):e169-74. PubMed ID: 26598102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report.
    Hultin S; Nahar K; Menzies AM; Long GV; Fernando SL; Atkinson V; Cebon J; Wong MG
    BMC Nephrol; 2020 Sep; 21(1):391. PubMed ID: 32894101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
    Cortazar FB; Kibbelaar ZA; Glezerman IG; Abudayyeh A; Mamlouk O; Motwani SS; Murakami N; Herrmann SM; Manohar S; Shirali AC; Kitchlu A; Shirazian S; Assal A; Vijayan A; Renaghan AD; Ortiz-Melo DI; Rangarajan S; Malik AB; Hogan JJ; Dinh AR; Shin DS; Marrone KA; Mithani Z; Johnson DB; Hosseini A; Uprety D; Sharma S; Gupta S; Reynolds KL; Sise ME; Leaf DE
    J Am Soc Nephrol; 2020 Feb; 31(2):435-446. PubMed ID: 31896554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events.
    Isik B; Alexander MP; Manohar S; Vaughan L; Kottschade L; Markovic S; Lieske J; Kukla A; Leung N; Herrmann SM
    Kidney Int Rep; 2021 Apr; 6(4):1022-1031. PubMed ID: 33912752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective study of drug-induced interstitial nephritis in eleven French nephrology units].
    Leven C; Hudier L; Picard S; Longuet H; Lorcy N; Cam G; Boukerroucha Z; Dolley-Hitze T; Le Cacheux P; Halimi JM; Cornec Le Gall E; Hanrotel-Saliou C; Arreule A; Massad M; Duveau A; Couvrat-Desvergnes G; Renaudineau E
    Presse Med; 2014 Nov; 43(11):e369-76. PubMed ID: 25218248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition.
    Hakroush S; Kopp SB; Tampe D; Gersmann AK; Korsten P; Zeisberg M; Tampe B
    Front Immunol; 2020; 11():624547. PubMed ID: 33552089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma.
    Patel V; Elias R; Formella J; Schwartzman W; Christie A; Cai Q; Malladi V; Kapur P; Vazquez M; McKay R; Pedrosa I; Hannan R; Hammers H; Brugarolas J
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33139246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review.
    Sise ME; Seethapathy H; Reynolds KL
    Oncologist; 2019 Jun; 24(6):735-742. PubMed ID: 30902916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
    Seethapathy H; Zhao S; Chute DF; Zubiri L; Oppong Y; Strohbehn I; Cortazar FB; Leaf DE; Mooradian MJ; Villani AC; Sullivan RJ; Reynolds K; Sise ME
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1692-1700. PubMed ID: 31672794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Checkpoint Inhibitor-Associated AKI: Debates in Diagnosis, Management, and Rechallenge.
    Seethapathy H; Herrmann SM; Rashidi A
    Semin Nephrol; 2022 Nov; 42(6):151346. PubMed ID: 37137187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritis.
    Miao J; Herrmann SM
    Clin Kidney J; 2023 Nov; 16(11):1834-1844. PubMed ID: 37915905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury.
    Sprangers B; Leaf DE; Porta C; Soler MJ; Perazella MA
    Nat Rev Nephrol; 2022 Dec; 18(12):794-805. PubMed ID: 36168055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
    Sise ME; Wang Q; Seethapathy H; Moreno D; Harden D; Smith RN; Rosales IA; Colvin RB; Chute S; Cornell LD; Herrmann SM; Fadden R; Sullivan RJ; Yang NJ; Barmettler S; Wells S; Gupta S; Villani AC; Reynolds KL; Farmer J
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facing the Challenge of Drug-Induced Acute Interstitial Nephritis.
    Sanchez-Alamo B; Cases-Corona C; Fernandez-Juarez G
    Nephron; 2023; 147(2):78-90. PubMed ID: 35830831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.
    Cortazar FB; Marrone KA; Troxell ML; Ralto KM; Hoenig MP; Brahmer JR; Le DT; Lipson EJ; Glezerman IG; Wolchok J; Cornell LD; Feldman P; Stokes MB; Zapata SA; Hodi FS; Ott PA; Yamashita M; Leaf DE
    Kidney Int; 2016 Sep; 90(3):638-47. PubMed ID: 27282937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper use.
    Min JW; Lim JU
    Semin Oncol; 2022 Apr; 49(2):141-147. PubMed ID: 35264308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.